Announcement on Voluntary Disclosure of Obtaining Lot Release by Company's Quadrivalent Influenza Vaccine for 2023-2024 Influenza Season
· Issued by Jiangsu Gdk Biotechnology Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Obtaining Lot Release by Company's Quadrivalent Influenza Vaccine for 2023-2024 Influenza Season
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View AttachmentCompany analysis
